Targeted therapy for systemic sclerosis
- 28 February 2006
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 5 (2) , 122-124
- https://doi.org/10.1016/j.autrev.2005.09.003
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Autoantibodies in Systemic SclerosisSeminars in Arthritis and Rheumatism, 2005
- Following the Molecular Pathways toward an Understanding of the Pathogenesis of Systemic SclerosisAnnals of Internal Medicine, 2004
- Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodiesArthritis & Rheumatism, 2003
- Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvementArthritis & Rheumatism, 2003
- NEW AND EXPERIMENTAL THERAPIES FOR PULMONARY HYPERTENSIONClinics in Chest Medicine, 2001
- Pulmonary hypertension in systemic sclerosis: risk factors for progression and consequences for survivalRheumatology, 2001
- Cyclophosphamide Is Associated with Pulmonary Function and Survival Benefit in Patients with Scleroderma and AlveolitisAnnals of Internal Medicine, 2000
- Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American populationArthritis & Rheumatism, 1998
- Severe restrictive lung disease in systemic sclerosisArthritis & Rheumatism, 1994
- Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosisBritish Journal of Dermatology, 1990